ANAGENESIS BIOTECHNOLOGIES
Startup
ANAGENESIS BIOTECHNOLOGIES
Description
ANAGENESIS BIOTECHNOLOGIES develops treatments designed for genetic and age-related muscle degenerative diseases with unmet medical needs and an expertise designed for rapidly building on proofâofâconcept muscles and BAT studies to generate other clinically significant tissues.
Resources
ANAGENESIS BIOTECHNOLOGIES
Address
850 BOULEVARD SEBASTIEN BRANT ILLKIRCH GRAFFENSTADEN 67400
FRANCE
FRANCE
Contact
contact@anagenesis-biotech.com
Description
ANAGENESIS BIOTECHNOLOGIES develops treatments designed for genetic and age-related muscle degenerative diseases with unmet medical needs and an expertise designed for rapidly building on proofâofâconcept muscles and BAT studies to generate other clinically significant tissues.
Resources
Matchmaking
Connect with ANAGENESIS BIOTECHNOLOGIES
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways